STOCK TITAN

BioCryst to Present at Upcoming Investor Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

BioCryst Pharmaceuticals (Nasdaq: BCRX) announced its upcoming presentation at the Cantor Global Healthcare Conference in New York. The presentation is scheduled for Thursday, September 4, 2025, at 9:45 a.m. ET. Investors can access both the live audio webcast and replay through the Investors & Media section of BioCryst's website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

%
1 alert
% News Effect

On the day this news was published, BCRX declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

RESEARCH TRIANGLE PARK, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the Cantor Global Healthcare Conference in New York on Thursday, September 4, 2025, at 9:45 a.m. ET.

The link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.

About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:
Investors:
investorrelations@biocryst.com

Media:
media@biocryst.com


FAQ

When is BioCryst (BCRX) presenting at the Cantor Global Healthcare Conference 2025?

BioCryst will present on Thursday, September 4, 2025, at 9:45 a.m. ET at the Cantor Global Healthcare Conference in New York.

How can investors access BioCryst's (BCRX) Cantor Conference presentation?

Investors can access the live audio webcast and replay through the Investors & Media section of BioCryst's website at www.biocryst.com.

Where is the 2025 Cantor Global Healthcare Conference being held?

The Cantor Global Healthcare Conference featuring BioCryst's presentation will be held in New York.

What time is BioCryst's (BCRX) presentation at the Cantor Conference?

BioCryst's presentation is scheduled for 9:45 a.m. ET on September 4, 2025.
Biocryst Pharmaceuticals Inc

NASDAQ:BCRX

BCRX Rankings

BCRX Latest News

BCRX Latest SEC Filings

BCRX Stock Data

1.65B
206.57M
1.26%
95.59%
13.09%
Drug Manufacturers - Specialty & Generic
Biological Products, (no Disgnostic Substances)
Link
United States
DURHAM